Trial
NCT02663271
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
NovoCure Ltd.
Condition
Glioblastoma Multiforme
Intervention
Bevacizumab
Why stopped
stagnant enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-23